Malignant neoplasm of middle third of esophagus
ICD-10 C15.4 is a billable code used to indicate a diagnosis of malignant neoplasm of middle third of esophagus.
Malignant neoplasm of the middle third of the esophagus refers to cancerous growths that occur in the central portion of the esophagus, which is the muscular tube connecting the throat to the stomach. This type of esophageal cancer can arise from the epithelial cells lining the esophagus and is often associated with risk factors such as smoking, heavy alcohol consumption, and gastroesophageal reflux disease (GERD). Symptoms may include difficulty swallowing (dysphagia), weight loss, chest pain, and persistent cough. Diagnosis typically involves endoscopy, imaging studies, and biopsy. Staging of esophageal cancer is crucial for determining treatment options and prognosis, with stages ranging from localized disease (Stage I) to advanced disease (Stage IV) with distant metastasis. Treatment may involve surgical resection, chemotherapy, radiation therapy, or a combination of these modalities. Surgical approaches can include esophagectomy, which is the removal of part or all of the esophagus, and may be performed via open surgery or minimally invasive techniques. The impact on swallowing function is significant, as patients may experience long-term dysphagia post-surgery, necessitating dietary modifications and possibly rehabilitation.
Detailed pathology reports, imaging studies, and treatment plans.
Initial diagnosis, staging, and treatment planning for esophageal cancer.
Ensure accurate documentation of tumor characteristics and response to treatment.
Endoscopy reports, biopsy results, and patient history.
Endoscopic evaluation of dysphagia and biopsy of suspicious lesions.
Document any findings related to GERD or Barrett's esophagus.
Performed for resection of malignant neoplasm of the esophagus.
Operative report detailing the procedure and findings.
Oncology and surgical documentation must align for accurate coding.
Common symptoms include difficulty swallowing, weight loss, chest pain, and persistent cough. Patients may also experience indigestion or heartburn.
